iXensor Co., Ltd. (TPEX:6734)
6.81
-0.05 (-0.73%)
Apr 29, 2026, 1:46 PM CST
iXensor Market Cap
iXensor has a market cap or net worth of 210.07 million as of April 29, 2026. Its market cap has increased by 18.28% in one year.
Market Cap
210.07M
Enterprise Value
206.56M
Revenue
26.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.81
Market Cap Chart
Since June 28, 2019, iXensor's market cap has decreased from 1.69B to 210.07M, a decrease of -87.58%. That is a compound annual growth rate of -26.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 210.07M | 17.26% |
| Dec 31, 2025 | 179.15M | 2.45% |
| Dec 31, 2024 | 174.86M | -61.87% |
| Dec 29, 2023 | 458.61M | -27.92% |
| Dec 30, 2022 | 636.21M | -13.24% |
| Dec 30, 2021 | 733.29M | -27.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diamond Biotechnology | 1.24B |
| Rossmax International | 1.19B |
| AViTA | 1.16B |
| PlexBio | 1.09B |
| Wiltrom | 1.07B |
| S&S Healthcare Holding | 925.75M |
| Radiant Innovation | 804.76M |
| AmCad BioMed | 778.99M |